Top compounds associated with response to SPATA25


Feature Type Standardized
Nominal ANOVA
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.039 0.3
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.039 0.3
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.036 0.3
mRNA QL-XII-47 GDSC1000 pan-cancer AAC -0.037 0.3
mRNA Merck60 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA PD-0332991 CCLE pan-cancer AAC -0.053 0.3
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA clofarabine CTRPv2 pan-cancer AAC -0.033 0.3
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
Download CSV